Treatment or prevention of proliferative conditions
JP2026104989APending Publication Date: 2026-06-25UNIV COURT OF THE UNIV OF DUNDEE
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- UNIV COURT OF THE UNIV OF DUNDEE
- Filing Date
- 2026-04-16
- Publication Date
- 2026-06-25
Smart Images
Figure 2026104989000001_ABST
Abstract
To provide novel compounds for use in the treatment or prevention of cancer and other proliferative conditions. [Solution] The present invention relates to novel compounds for use in the treatment or prevention of cancer and other proliferative conditions, characterized, for example, by cells expressing cytochrome P450 1B1 (CYP1B1) and its allele variants. The present invention also provides pharmaceutical compositions comprising one or more such compounds for use in medical therapies, for example, in the treatment or prevention of cancer or other proliferative conditions, as well as methods for treating cancer or other conditions in human or non-human animal patients. The present invention also provides methods for identifying novel compounds for use in the treatment or prevention of cancer and other proliferative conditions, characterized, for example, by cells expressing CYP1B1 and its allele variants. The present invention also provides methods for determining the efficacy of the compounds of the present invention in cancer treatment.
Need to check novelty before this filing date? Find Prior Art
Claims
[Claim 1] The need for a compound for treating a proliferative state.